chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got metallic taste in mouth with 15 min of receiving both shots. After both shots it went away in 2 days but it reappeared 10 days after 2nd shot and it hasnt gone away yet and its been 5 days.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 05Mar2021 at 01:45 (at the age of 60-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 31Mar2021 at 01:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included calcium (MANUFACTURER UNKNOWN) and multivitamin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 at 02:00 and 31Mar2021 at 02:00, the patient got metallic taste in mouth with 15 min of receiving both shots. After both shots it went away in two days but it reappeared ten days after second shot on 10Apr2021 and it hadn't gone away yet and it had been five days at the time of report. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event got metallic taste in mouth with 15 min of receiving both shots, after both shots it went away in two days but it reappeared ten days after second shot  and it hadn't gone away yet was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
patient complains of lips tingling. patient monitored for additional 30 mins. no progression of symptoms. patient states feeling better at time of departure.
06-17-09  Fainting episodes x2 after vaccines given.  Recovered x1 after glass of water given.  Second time it was difficult to wake her, shallow breathing, skin cold and clammy to touch.  911 called.  Vomitted x1. BP-74/50, P-68. Prior to the 2nd fainting episode she had tonic clonic movements noted in arms, bilaterally, eyes rolled back, incoherent.
Vaccine that was given was expired. Vaccine was diluted and drawn up at 2pm on 6/23/21 and expired on 6/23/21 at 8pm. Dose was given at 9:20am on 6/24/21.
Called hospital callc center to report c/o swelling mouth, headache, body ache, weakness, severe anxiety. Advised pt to go to ED .
Headache the afternoon/evening the shot was given. Skin reaction 2 inches in diameter at injection sight for 9 days that is red, sore, hard, hot to the touch, and itchy.
Two doses and 8 months later got shingles; Lyme Disease at same time; Shingles Terrible! Still have flair ups; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, 8 months after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), lyme disease (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and lyme disease were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, lyme disease and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The patient reported that, he/she had the two dose of Shingles vaccine and 8 months later got shingles on my face and on his/her scalp was terrible. The patient's doctor said good thing the patient got the vaccines, as it could had been worse. The patient stated that was a year ago and he/she still had flair ups.  The patient stated that he/she also got Lyme disease at the same time, when the patient got shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation for shingles was unknown at the time of reporting.
Pt came in office for well visit-due for 10/4/18 vaccine update. Pt ask to also get tetanus vaccine-Had her spleen remove and it been greater than 10 years. Pt was given Tetanus IM (R) middle deltoid Flu vaccine IM (R) posterior deltoid.
Syncope Narrative:  Patient experienced a syncope event post covid vaccine. Pt recovered on own. Pt was monitored by staff. No treatment required.
Patient received vaccine after expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter. On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. No treatment medication was provided.
Arm swelling started 8/27/07 and is improving. Wheezing started at night on 8/28/07; was seen on 8/30/07. Started Benadryl and Pepcid/Zantac, Albuterol.
The pt experienced a rash and pruritis. The rash started on upper back and abdomen, chest and arms. MD thought it may be reaction to flu shot.
I did not have a reaction to the vaccine. On 11/25/2022, I started having symptoms of a sore throat, runny nose and a cough. I have a lot of allergies and I didn't think anything else about it. On 12/02/2022, I tested positive for COVID-19. I contacted my doctor and was advised to take it easy but keep moving and use guaifenesin for the cough. As of today, I seem to want to sleep more than I usually do.
This is a spontaneous report from a contactable consumer (patient's parent), via Medical Information Team. A male patient of an unspecified ethnicity received TRUMENBA, first dose at age 16 (unit unknown) on an unspecified date and the second dose at age 17 (unit: unknown) on 07Aug2017 (reported as yesterday), both via an unspecified route of administration at a single dose for immunization, (the time between the two doses was not specified). The patient's medical history and concomitant medications were not reported. On an unspecified date, after the patient's first dose he had some pain at the injection site, but now after the second one he was not feeling well in general, he had a lot of pain in his arm, back pain, and fever. The outcome of the events was unknown.
HIGH TEMPERATURE; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced high temperature. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103.4 to 103.1 F. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient was recovering from high temperature. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
L shoulder - most superior aspect, aspect with 2cm black & blue bruise. Completely inferior but centrifuge is a 12x12cm area of redness, mild induration, mild warmth, but no significant tenderness. In future consider benadryl with flu vaccine.
Elongated red rash with pink swelling which goes from injection site to near elbow.  Went to Emergency Center, checked by doctor, and given prescription for Cephalexin (500mg 3 times a day)which I am currently taking.
Received Flu vaccine Hx of sensitivity to eggs. C/O itching and pruritus after vaccine.
Pt received varivax vaccine sc in left arm.  Patient was seen in Emergency Room on 07/10/09 for redness at site on left arm.  Treated with Keflex.  Seen in office 07/11/09 and had an area of redness approx 2.5 cm x 2.5 cm in size.
Information has been received from a physician for the pregnancy registry for GARDASIL concerning a female patient who in September 2009, was vaccinated with the first dose of GARDASIL. In November 2009, the patient received her second dose of GARDASIL. It was reported that the patient went to the physician's office and was told she is pregnant and is due 01-DEC-2010. The patient sought unspecified medical attention. The physician reported that the patient will receive the third dose of GARDASIL after the pregnancy. The last menstrual period was on 24-FEB-2010. No adverse event involved. Follow up information received from a physician indicated that the patient was a 26 year old female with a previous full term pregnancy; mild depression, anxiety and a medical history seizure (last in 2004). Concomitant therapy included prenatal vitamins. On 27-APR-2010 at 8 weeks of pregnancy, she had an ultrasound for dates. The patient declined the amniocentesis and the MSAFP. Follow up information has been received from a licensed practical nurse concerning the female patient with no infections or illnesses during pregnancy and with no concurrent medical condition or family history. The nurse reported that on 24-NOV-2010 at 39 weeks from LMP, the patient delivered a male baby with 8 pounds and 14 ounces of weight and 21 inches of length, apgar score 8/9. The infant was normal. There were no congenital anomalies. There were no other complications or abnormalities. There were no complications during pregnancy. During labor the patient experienced secondary laceration perineum. No diagnostic test was performed during pregnancy. At the time of the report, the patient's outcome from secondary laceration perineum was unknown. Follow up information has been received from the physician indicating that the patient delivered laceration was not due to vaccine. No further information is available.
Altered mental status, slurred speech, facial droop on 6/24/21.  Was admitted to hospital on 6/25/21 and diagnosed with acute stroke - right frontoparietal.
he is scared; numbness in his fingers; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age reported for himself that he received BNT162B2 (Comirnaty, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on an unspecified date in Aug2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Aug2021, five days later, the patient experienced numbness in his fingers. The patient was scared and asked what he should do and if he should receive the second vaccine. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient presented to receive 2nd dose of Moderna Covid Vaccination.  Had identified as no problem with the 1st dose.  Patient was nervous/apprehensive about vaccine and had a childhood history of Syncope with vaccinations/needles.  Patient received vaccine and was ok, while waiting in observation pt. had expressed that he was feeling cold, light headed and dizzy.  I was notified and stabilized pt. to prevent falling/sliding from passing out, pt. never lost consciousness and provided pt. with cold compress which relieved pt. symptoms and transported pt. onto floor incase of loss of consciousness, which never occurred.  Patient recovered and felt fine.
Right upper arm from injection site (below shoulder area) to elbow swelling, warmth, redness. Hives under left eye, followed by swelling in both eyes the morning after initial hive symptom appeared. Ongoing treatment with Claritin and Benadryl. Still with swelling to R upper arm, and reduced swelling to eyes.
Vaccinating RN administered vaccine superior to deltoid muscle target area, observed by FNP on duty to be near joint.  An immediate red, indurated area appeared, approx. 30mm in diameter.   Recipient denied pain, discomfort and had no impact on range of motion.  Patient was observed for 30 minutes, reassessed and provided precautionary guidance by FNP on duty prior to leaving the clinic.  No other clinical manifestations presented during observation period.
started with diarrhea yesterday afternoon and it has continued to present. He also threw up once at about 1:30 am on 12/17/21.
Redness at vaccine site - ( R ) thigh. ? local Rx. ~ area warm rxn pos about 3x4 cm but about 2 cm to side of injection site.
Patient was vaccinated earlier than the recommended time allowed between Covid Vaccines in the series.  Second dose was administered 10 days after the first dose. No adverse reactions were observed. Patient was assessed and was found to be stable.
PATIENT DEVELOPED RED PATCHES (ABOUT 6 INCHES) ON THE INSIDE FOLD OF BOTH ELBOWS ON 06/18/2018, 3 DAYS AFTER GETTING THE SHINGRIX VACCINE, SHE COMPLAINED ABOUT ITCHING AND PAIN. SHE WENT AND SAW HER DOTOR ON 6/19/2018. PER PATIENT, HER DOCTOR WAS NOT SURE THAT IT WAS ALLERGIC REACTION TO VACCINE. SHE PRESCRIBED STEROID TO HELP WITH THE ITCHINESS. I JUST TALKED TO PATIENT TODAY 6/23/2018, SHE SAID THAT IT WAS A LITTLE BETTER, AND SHE STOPPED USING THE MED A COUPLE OF DAYS AGO. SHE ALSO NOTICED THAT THE SAME REDNESS WERE ON HER BREAST, BEHIND LEG, STOMACH THE DAY AFTER SHE STOPPED USING THE STEROID. THIS MORNING SHE NOTICED BLISTER ON HER BREAST AND SHE HAS AN APPOINTMENT WITH DOCTOR THIS COMING WEDNESDAY.
Mild HeadAche; Mild Body Aches for 36 Hours; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-year-old elderly male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6205), via an unspecified route of administration, administered in left arm on 02Mar2021 22:15 (at the age of 66-year-old) at a single dose for covid-19 immunisation. The patient's medical history included arthritis. The patient had no allergies. Concomitant medication included naproxen (NAPROXIN [NAPROXEN]). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EM9810), via an unspecified route of administration, administered in left arm on 09Feb2021 01:15 PM (at the age of 66-year-old) at a 1st dose, single dose for covid-19 immunisation. The patient experienced mild headache, mild body ache for 36 Hours on an unspecified date in 2021. No treatment was given for adverse event. Patient did not had COVID prior vaccination and did not had COVID tested post vaccination. Patient did not had other vaccine in four weeks. Outcome of the events was resolved on an unspecified date in 2021.  No follow up attempts are possible. No further information is expected.
9/13 developed cellulitis at the site of Varicella injection left arm.   9/30 developed pox disseminated.
Elevated liver function after receiving vaccine. ALT :363 and AST 164, fatigue, nausea and headache. Shot was given on 07/30/22 and labs taken 08/05/202 and then ER of hospital on 08/07/22. CT was normal and showed no liver inflammation nor other signs of neighboring organs compromised.
This is a spontaneous report from a contactable consumer (billing manager) via Pfizer sales representative. A 18 year-old female patient of unspecified ethnicity received TRUMENBA via an unspecified route of administration, on unknown date, at a single dose. Relevant medical history and concomitant medications were not reported. The patient experienced localized redness and pain at the injection site on unknown date, two days after receiving the injection. The outcome of the events was unknown.
Itching all over the body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced PRURITUS (Itching all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all over the body) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: No specific follow-up information recorded.
Immediately following HiB injection to RAT; thigh swelled, hot to touch and red. Cool moist compress applied. Pt held in office. Thirty-five minutes later swelling down and redness decreased. Pt release with instruction to continue cool compresses. Mom to phone office if any change.
About 15 min after the pt received the 2nd Moderna covid vacdine, he started complaining of dizziness. BP 118/66, HR 64, SpO2 98% RA. About 15 min later he is dizzy, eyes watering, with blurry vision. Pt waited about 30 min more BP 138/82, HR 58, SpO2 99% RA. Pt said vision still blurry but getting better. Dizziness resolved.
Information has been received from a physician and a consumer concerning her 19 year old daughter with no previous medical history and allergies reported, who on 01-OCT-2008 a nurse practitioner inadvertently gave another dose of GARDASIL. The patient experienced injection site pain after received the fourth dose of GARDASIL . The patient had completed a series during the summer. Concomitant therapy included meningitis vaccine (manufacturer unspecified) and TB shot (manufacturer unspecified). The patient did not seek medical attention. The patient did not have illness at time of vaccination. Additional information has been requested.
I ended up at the er because I had severe hives all Over my body. It was on my legs, face, neck, vaginal, etc. I was prescribed 40 mg of prednisone for 5 days.
received the second covid injection 2/3/2021 at about 1pm. The typical symptoms began with soreness at injection site. Then random joint pain, muscle aches and stiffness. During the night muscle ache turned to pain radiating around upper abdomen up into right shoulder as did the injection site with nausea, stomach upset and gas. 2/4/2021 around 9am the chills started and fatigue, increased muscle aches and chills with difficulty controlling my bladder, in addition my urine turned dark. 2/5/2021 all the same symptoms with increased discomfort around upper abdomen circling to my back and new muscle twitching at the injection site. All continued through 2/7/2021 and began lessening. Starting 2/8/2021 mild aches and random chills with upper abdominal pain continuing. At night for some reason it all starts again, I wake up wet from perspiration every night and I switch from painful chills with aches and pain to being hot.
Missed dosing window; A spontaneous report was received from a consumer concerning a 70-year-old, female patient, who received only the first dose of the Moderna's COVID-19 vaccine (mRNA-1273) and missed the second dose becoming out of window by the time of the report.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 07-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025L20A ) intramuscularly for prophylaxis of COVID-19 infection.   By 26-Feb-2021, the patient missed dosing window. Her daughter called to ask if the patient has to start over with the vaccination schedule.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event was resolved; Reporter's Comments: This report refers to a case of missed second dose of mRNA-1273, lot not applicable, with no associated AEs.
headache, sore throat, chills, shortness of breath, body aches, diarrhea, sinus congestion, nasal congestion, post nasal drainage, dizziness. starting 1/16/22
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug allergies/reactions were not provided. On an unspecified date, the patient was vaccinated with improperly stored GARDASIL 9 (incorrect product storage) lot#: N004798, expiration date: 31-OCT-2019 for prophylaxis (dose, frequency and route of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of 32 degree Fahrenheit to 35 degree Fahrenheit for 6 hours. There were no adverse effects reported. There was no previous temperature excursion. Digital Data logger was involved. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA010758: US-009507513-1709USA010561:
Tingling in the face rash and swelling around injection sites and rash around lips/face.
Information has been received from a mother concerning her 18 year old daughter who on 14-DEC-2006 was vaccinated with Gardasil (lot # not reported) IM. Concomitant therapy included "TENUS therapy unspecified and hepatitis A virus vaccine (unspecified)" date not provided. The mother reported that her daughter fainted and also experienced pain in her arm after receiving Gardasil. The onset date was reported as 24-Dec-2006. At the time of reporting, the patient had recovered. Additional information has been requested. Information has been received from a mother concerning her 18 year old daughter who on 14-DEC-2006 was vaccinated with a first dose of GARDASIL (lot # 654389/0961F) IM in the left arm. Concomitant therapy also given on 14-DEC-2006 included a first dose of HEPATITIS A virus vaccine inactivated (Lot # 656495/1209P) in the left arm and a first dose of ADADEL (lot # 538AA) given in the right arm. The mother reported that her daughter fainted and also experienced pain in her arm after receiving GARDASIL. The onset date was reported as 27-DEC-2006.At the time of reporting, the patient hasd recovered. Additional information was received from the phyhsician. The patient fainted on 14-DEC-2006 and subsequently recovered. On 12-MAR-2007, the patient was vaccinated withthe second dose of GARDASIL (lot # 654389/0961P) in the right arm. No reports of fainting, no problem. No additional information is expected.
Had Varivax 11/03/1999 at clinic. Broke out with chicken pox 11/03/2001.